Improvement in symptoms at ≤ 3 months · carpal tunnel syndrome
1 finding from 1 review
Improvement in function at ≤ 3 months · carpal tunnel syndrome
1 finding from 1 review
Improvement in symptoms at > 3 months · carpal tunnel syndrome
1 finding from 1 review
Improvement in neurophysiological parameters at ≤ 3 months · carpal tunnel syndrome
1 finding from 1 review
Requirement for carpal tunnel surgery · carpal tunnel syndrome
Local corticosteroid injection (LCI) probably leads to lower requirement for carpal tunnel surgery compared with saline no treatment or placebo (moderate certainty).
1 finding from 1 review
Improvement in quality of life · carpal tunnel syndrome
1 finding from 1 review
Adverse events · carpal tunnel syndrome
1 finding from 1 review
Induction of labour · people with multifocal motor neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Induction of labour · people with multifocal motor neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Maintenance · people with multifocal motor neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of IVIg‐treated participants with an increase in disability during controlled IVIg withdrawal · people with multifocal motor neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Muscle strength · people with multifocal motor neuropathy
1 finding from 1 review
no estimate extracted
9 participants
Very low
Adverse events · people with multifocal motor neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with side effects attributable to treatment · people with multifocal motor neuropathy
It is very uncertain whether IVIg changes proportion of participants with side effects attributable to treatment compared with SCIg (very low certainty).
1 finding from 1 review
RR 0.5 [0.18, 1.4]
9 participants
Very low
Proportion of participants with an improvement in disability scale used in the original study · people with multifocal motor neuropathy
IVIg showed no clear difference in proportion of participants with an improvement in disability scale… compared with placebo (low certainty).
1 finding from 1 review
RR 3 [0.89, 10.12]
18 participants
Low
Proportion of participants with an improvement of muscle strength · people with multifocal motor neuropathy
IVIg may leads to higher proportion of participants with an improvement of muscle strength compared with placebo (low certainty).
1 finding from 1 review
RR 11 [2.86, 42.25]
27 participants
Low
Proportion of participants with an improvement in disability at 12 months or later · people with multifocal motor neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants in which at least 1 conduction block resolved after therapy · people with multifocal motor neuropathy
IVIg showed no clear difference in proportion of participants in which at least 1 conduction block… compared with placebo (low certainty).
1 finding from 1 review
RR 7 [0.95, 51.7]
28 participants
Low
Maintenance · people with multifocal motor neuropathy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of IVIg‐treated participants with an increase in disability during controlled IVIg withdrawal · people with multifocal motor neuropathy
IVIg probably leads to higher proportion of IVIg‐treated participants with an increase in… compared with placebo (moderate certainty).
1 finding from 1 review
RR 2.43 [1.13, 5.24]
42 participants
Moderate